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Abstract 
Study objective:  To investigate whether the phase of menstrual cycle has influence on 
the incidence of PONV in women undergoing general anesthesia for elective 
laparoscopic gynecological surgery. 
Design: A prospective, observational, blinded study.  
Settings: General hospital, postanesthesia care unit (PACU) and gynecologic floor room. 
Patients: 111 ASA physical status I and II women, aged 18 to 53 years. 
Interventions: Patients were classified into three groups according to the phase of 
menstrual cycle at the time of anesthesia: F1 - follicular phase (menstrual days 1-8) 
(n=34), O2 - ovulatory phase (9-15) (n= 40) and L3 - luteal phase (16 to end of cycle) 
(n=37). Anesthetic, postoperative pain management and antiemetic regimen were 
standardized.  
Measurements: Incidences of nausea, vomiting or both were assessed for early (0-2h) and 
late PONV (2-24h) along with the use of rescue antiemetic, severity of nausea and pain. 
Main results:  In the follicular (n=34), ovulatory (n=40) and luteal phase (n=37) groups  
the incidences of PONV over 24 hours were 35%, 38% and 14% (p=0.04), respectively. 
This was due to differences in the early postoperative period where the incidences were 
21%, 25%, and 3%, (p=0.02) as incidences were similar in the late period (15%, 20% and 
14%, p=0.71), respectively. Nausea scores, rescue antiemetic usage, pain scores and 
opioid consumption were similar in the groups. 
Conclusion:  Patients in the luteal phase of  their menstrual cycle might have a decreased 
risk of  PONV after laparoscopic gynecological surgery in the early postoperative period. 
Introduction  
 
Female sex is a known independent predictor for postoperative nausea and vomiting 
(PONV) [1]. Women have 2 to 4 times higher PONV risk than men [2]. The increased 
risk is not seen in children before puberty [3] and in postmenopausal women over 50 
years of age the incidence is decreasing but it is still higher than in men [4]. This suggests 
a role of sex hormones in the etiology. Indeed, estrogen levels may influence PONV after 
general anesthesia for gynecological laparoscopy [5]. Furthermore, menstrual cycle 
irregularity often corresponds to hormonal disturbances and also increases the risk of 
PONV [6].  
Sex hormone variations during menstrual cycles and their influence on PONV are not 
well studied. Recent guidelines of the Society for Ambulatory Anesthesia for the 
management of PONV did not identify menstrual phase as an independent predictor for 
PONV [2]. A meta-analysis of 12 studies in different surgeries suggested no significant 
influence of the day or phase of the menstrual cycle on PONV [7], but gynecological 
laparoscopic surgery was not analyzed separately. Gynecologic laparoscopic surgery may 
have an increased incidence of PONV compared to the other surgeries [2], suggesting 
that additional predictors and/or mechanisms of PONV may be involved. Indeed, a large 
multicentre study (IMPACT study) reported that only hysterectomy had significantly 
increased odds ratio for PONV (1.94; CI 1.43, 2.63; P<0.001) compared with all other 
surgeries [8].  
Published studies on the influence of the menstrual cycle on PONV in gynecological 
laparoscopy reported controversial results. While the follicular phase of the menstrual 
cycle increased the risk for PONV in some studies [9-11], the luteal phase increased the 
risk in another [12]. Moreover both phases, follicular and luteal increased the risk in one 
study [13] but not in a multicentre study [14] or a factorial trial of six interventions for 
the prevention of PONV (IMPACT study) [8] (Table 1).  
We designed a prospective, observational study that was controlled for known 
independent PONV predictors to determine whether the menstrual cycle phase influenced 
on PONV in fertile women with regular cycles undergoing general anesthesia for elective 
laparoscopic gynecological surgery. 
Materials and methods 
 
After approval by the  Ethics Committee of the General Hospital, Zadar, Croatia,  and 
written informed consent, 111 adult fertile women receiving general anesthesia for 
elective laparoscopic gynecologic surgery were included in the study. The study was 
conducted from April 2007 to May 2009 at the General Hospital, Zadar. Inclusion criteria 
were ASA physical status (ASA-PS) I and II and a regular menstrual cycle. We defined a 
regular cycle as lasting 23 days to 35 days with no variations in length from cycle to 
cycle more than two days. The day of the cycle on which surgery took place was 
calculated from the first day of the last menstrual bleeding.  
Exclusion criteria were pregnancy; those receiving hormones and medications that 
affected ovulation during the 6 weeks before surgery; those who had given birth or who 
were less than two months from termination of pregnancy; breast-feeding; obesity (BMI 
>30 kg/m²);  known hypersensitivity to drugs used in the study protocol; use of 
antiemetics, psychotropic drugs and steroids within 72 hours before the surgery; nausea 
and vomiting prior the surgery;  history of abdominal laparatomies; comorbidities that 
may have an influence on PONV like diseases which impaired gastric motility (diabetes 
mellitus, chronic cholecystitis, gastric and intestinal disease, neuromuscular disorders, 
neuropathies, liver dysfunction), vestibular disease, history of migraine headache, central 
nervous system injury, renal impairment, alcoholism and opioid addiction. Patients were 
excluded from the study if they developed conditions that influence incidence of PONV 
such as intraoperative drug allergy, severe intraoperative hypotension, perioperative 
hypoxia, excessive blood loss, difficult intubation, laparoscopic procedure converted to 
laparotomy or if serious postoperative complications developed.  
Patients were classified into the three groups on the basis of the phase of the menstrual 
cycle at the time of surgery: Group F1- follicular phase (days 1- 8); Group O2-ovulatory 
phase (days 9-15); and  Group L3-luteal phase (days 16 to end of cycle). Patients fasted 
at least 6 hours but allowed to drink clear fluids up to three hours before surgery. All 
patients received 7.5 mg of midazolam orally 1 hour before surgery and no prophylactic 
antiemetics, which was the standard of care in our hospital.  
Standard monitoring was used including electrocardiography, noninvasive blood 
pressure, pulse oximetry and capnography. Anesthesia was induced with thiopental 5 
mg/kg and fentanyl 1-2 µg/kg. Patients were manually ventilated via face mask with 
oxygen for three minutes before endotracheal intubation facilitated by intravenous (IV) 
vecuronium 0.1 mg/kg. Anesthesia was maintained with sevoflurane 1.5-2% 
concentration (end tidal concentration ~ one minimum alveolar concentration [MAC]) in 
a gas mixture consisting of 40% oxygen in air. Supplemental bolus doses of fentanyl IV 
(1 µg/kg) to keep heart rate and blood pressure within 20% of baseline values were given, 
as well as, additional vecuronium to maintain a one or two twitches on the train-of-four 
monitor. All patients received 10 ml/kg/h of crystalloids during surgery. A nasogastric 
tube was not placed. Patients were mechanically ventilated to keep normocapnia (end 
tidal CO2 36-38 mmHg). All laparoscopies were performed with intraabdominal CO2 
insufflation. Sevoflurane was discontinued at the start of skin closure. At the end of 
surgery, neuromuscular blockade was antagonized with neostigmine 2.5 mg and atropine 
1 mg IV. Postoperatively, patients received 5 ml/kg/h of crystalloids and were allowed to 
drink after three hours, if tolerated. All patients stayed in the hospital for at least 24 
hours. 
 The incidence of postoperative nausea (PON), vomiting (POV) and the use of rescue 
antiemetic were collected at 2 and 24 hours after surgery. Severity of PON and pain were 
evaluated using a 100 mm visual analog scale (VAS) at the same time points (VAS 0 = 
no pain/nausea, 100 = maximal pain/nausea). On the day of surgery, anesthesiologist who 
collected patients' data also instructed each patient in VAS scoring. A VAS score for 
PON was measured for each episode, but the highest score was used for the statistical 
analysis. Patients were considered to have had PONV if they experienced at least one 
episode of nausea, vomiting or retching or any combination of these during the first 24 
postoperative hours. POV was defined as at least one episode of vomiting or retching that 
occurred within 24 postoperative hours. PONV was defined as early (within first two 
hours in postoperative recovery area) or late (within two to 24 postoperative hours on the 
ward). Three clinical nurses who were specifically trained for the study and were blinded 
to study group allocation, collected the data.  Rescue antiemetic (metoclopramide 0.4 mg 
/kg IV) was given to patients who experienced two or more episodes of vomiting and /or 
retching within a period of 30 min, any nausea lasting more than 15 min or nausea VAS 
score 50 mm or greater, or when they requested treatment. Pain VAS score and total 
amount of postoperative opioids were recorded at 2 h and 24 hours after surgery. 
Intramuscular (IM) diclofenac 75 mg was given immediately after surgery and, if needed, 
12 hours later. For severe pain (VAS >40 mm) meperidine up to 100 mg IV was given, 
then repeated 4 hours later if needed. The incidence of early and late PONV was the 
primary endpoint of the study and the use of rescue antiemetic, severity of nausea and 
pain were the secondary endpoints. 
Sample size calculation was based on the incidence of  PONV that was recorded in our 
preliminary study: 29% in the follicular phase (days 1-8), 40% in the ovulatory phase 
(days 9-15) and 15% in the luteal phase group (days 16 to end of menstrual cycle) [15]. 
All patients from the preliminary study were included in this study. Power analysis, using 
PASS (Power Analysis and Sample Size) 2008, version 8.0.5 software (NCSS, Kaysville, 
UT, USA) showed that a total of 108 patients, or 36 per group, was sufficient to 
demonstrate a 30% difference in PONV incidence, with effect size w=0.3 and 80% power 
at a 2-sided α level of 0.05. A total of 111 patients were enrolled in the study so as to 
allow for a 3% dropout rate. Data were analyzed using statistical program SAS 8.2 (SAS 
Institute, Chicago, IL, USA). Quantitative values were analyzed using the Kruskal-Wallis 
and Mann Whitney tests and categorical data by Pearson Chi-Square analysis and 
Fisher’s Exact test. Risk scores for PONV were calculated according to Apfel et al. [1]. A 
P value < 0.05 was considered statistically significant. 
Results 
 
All 111 patients successfully completed the study (Figure 1). Data from all patients were 
included in the statistical analysis. According to the phase of menstrual cycle at the time 
of surgery, 34 patients were assigned to the follicular group (Group F1), 40 patients to the 
ovulatory group (Group O2) and 37 to the luteal phase group (Group L3). Patients’ 
demographic and intraoperative data did not differ among the three groups except in 
duration of anesthesia between Groups L3 and O2 (Table 2). There were no differences 
with respect to calculated PONV risk score (P=0.29) (Table 2). 
There was an overall statistically significant difference for PONV at 24 hours. This 
finding was due to differences in the early postoperative period (0-2 h) where the 
incidences were lowest in Group L3 (Table 3). There was no difference in late PONV (2-
24 hrs), nausea at 24 hours or late nausea and VAS scores for nausea (Table 3). Although 
the incidence of postoperative vomiting (POV) was lowest in Group L3 in early POV and 
at 24 hours, the difference did not reach statistical significance (Table 3). There was no 
difference in the incidence of severe nausea: Group F1=3 (9%), Group O2=5 (13%) and 
Group L3=2 (5%) or severe POV: Group F1=1 (3%), Group O2=1 (3%) and Group L3=1 
(3%). Also, there was no difference in the number of patients who received 
metoclopramide: Group F1=5 (15%), Group O2=5 (13%) and Group L3=2 (5%). The 
VAS pain scores at 2 h and 24 hours after surgery were similar among the groups, as well 
as, total amount of intraoperative opioids and postoperative pain medications given 
(Table 4). No adverse events among any patients were noted during the study period. 
Discussion 
 
This pilot study suggests that the incidence of PONV in the early postoperative period 
after gynecologic laparoscopic surgery is decreased in the luteal phase of the menstrual 
cycle compared with the follicular and the ovulatory phases of the cycle. In the early 
postoperative period, the incidence of nausea but not of vomiting was decreased during 
the luteal phase.  The results of this study were similar to studies that suggested that the 
early phase of the cycle increases risk of PONV [9-11], but differed with those that 
determined that the luteal phase was a predictor of PONV [12, 13] and likewise to those 
studies that found no influence of the cycle on PONV [14, 16, 17]. Small, single-center 
studies may not have enough power to answer the question, but a subsequent meta-
analysis may be helpful. Indeed, meta-analysis by Eberhart et al suggested that menstrual 
cycle phase had no impact on PONV [7]. Their study found no differences in incidence of 
PONV among the different phases of the cycle but showed the highest incidence of 
PONV on postoperative day (POD) 5 and the lowest incidence from POD 16 to 21, a 
finding that was similar to our own [7]. 
One of the major issues in studying the influence of menstrual cycle is inconsistent 
definitions of menstrual phases and variation of menstrual cycle from woman to woman 
and from cycle to cycle. Clinical prediction of the ovulatory phase is uncertain. On 
average, ovulation is calculated 14 days prior to the next menstruation but it may vary 
from 10 to 16 days or more. Moreover, menstrual cycle irregularity may contribute to the 
increased risk of PONV [6]. For this reason we included in our study only those patients 
with the regular cycles of average duration (28±1.3 days). During a regular menstrual 
cycle, there are two surges in estrogen levels, in the ovulation and the luteal phase, and 
one progesterone surge, which occurs during the luteal phase. We divided the menstrual 
cycle into three phases to evaluate all three hormonal states during the cycle: follicular 
phase with both, estrogen and progesterone low, ovulatory phase with estrogen high, and 
luteal phase with both estrogen and progesterone high. We believe that this is a more 
physiologic approach than studies with two groups only (menstrual vs non-menstrual) or 
5 groups (premenstrual, menstrual, follicular, periovulatory, luteal). 
The increased incidence of PONV in women, which starts with the fertile period, as well 
as, during pregnancy, suggests the involvement of sex hormones in the PONV 
mechanism [18]. It is unclear which are the responsible hormones. Estradiol, not estriol 
or progesterone, increases vomiting during pregnancy [19]. Estrogen also may be 
involved in the increased incidence of PONV [5]. 
The studies of PONV have not measured sex hormone levels perioperatively. This fact 
may explain the controversial results reported on the influence of menstrual cycle on 
PONV after gynecological laparoscopy (Table 1). Only three abstracts and one paper 
have attempted to correlate hormonal levels, with completely different results 
[5,16,17,20]. One report suggested that higher estradiol levels increased risks for PONV 
[5]; another showed that the lower levels were associated with PONV in the 
perimenstrual phase but not across the cycle [20]; a third report stated that PONV patients 
had lower mean estradiol levels regardless of cycle [16], and finally, the paper (in 
Korean) that suggested that estradiol had no influence on PONV at all [17]. One 
measurement preoperatively may not be sufficient to confirm the phase of the cycle. The 
change in hormone levels may be more important, as well as the relative ratios among 
estrogen, estradiol, and progesterone. A study with serial hormone measurement may 
provide the definitive answer. 
There are several limitations to this study. Although, duration of anesthesia was greater in 
Group L3 (luteal phase) than Group O2 (ovulatory phase), we do not think that this 
influenced our conclusions since the longer duration of anesthesia is associated with 
increase incidence of PONV not lower. We did not use PONV prophylaxis in this study, 
as it was the hospital's policy not to use pharmacological prophylaxis. The results of this 
study may not be reproducible in the patients receiving PONV prophylaxis. Although, we 
enrolled patients with a regular cycle, the ovulation date was estimated. The possibility of 
nonovulatory cycles also may have biased the results. Hormonal measurements and/or 
ultrasound examinations to confirm ovulation and phase of cycle were not performed. 
The high cost of the tests and repeat hormonal measurements in relatively young, healthy 
and ambulatory patients before surgery may render a study difficult to conduct. The other 
option, in clarifying the influence of the menstrual cycle on PONV, is to schedule the 
date of the surgery according to the cycle phases. For example, patients with a regular 
cycle may be prospectively randomized to have surgery either few days after 
menstruation (follicular phase) or two to three weeks after menstruation (luteal phase). 
Scheduling a gynecologic surgery in the luteal phase of the menstrual cycle may not be 
popular in some surgeons who like to avoid manipulations around the yellow body 
(corpus luteum) during gynecological surgery. Furthermore, the risk of perioperative 
bleeding may be higher in the luteal phase than the follicular phase of the cycle [21]. On 
the other hand, perioperative blood loss was increased during the perimenstrual phase 
compared with the periovulatory phase in breast reduction surgery [22]. The effect of 
menstrual phases on perioperative bleeding in gynecologic laparoscopic surgery is not 
known. However, in this study perioperative blood loss was minimal in all surgeries. 
In conclusion, in the luteal phase of the menstrual cycle after gynecologic laparoscopic 
surgery, the incidence of PONV may be decreased in the early postoperative period. 
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Figure 1. Flow diagram of patients’ distribution. 
 
 
 
123 patients 
recruted 
 
 
38 allocated to the 
follicular phase (days 1-8) 
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ovulatory phase (days 9-
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1 irregular cycles 
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34 analyzed 
 
40 analyzed 
 
37 analyzed 
TABLE 1 Studies about the influence of menstrual phase on the incidence of PONV cited. 
Reference [Number] 
type of study 
Type of anesthesia/ 
surgery 
PONV 
prophylaxis 
Groups [Menstrual cycle days]   
( N ) 
Outcomes and
PONV incidence (%)
Eberhart et al., 
2000.[7] 
Systematic review 
general or regional, different 
techniques/ mixed surgery 
yes=1468 
no =1157 
(N=2625) 
[1-7] 
[8-12] 
[13-15] 
[16-24]  
[25 – end of cycle]  
PONV at least 12 hours 
40.4% 
32.9% 
38.1% 
34.5% 
41.5% 
Beattie et al.,  
1993. [9] 
Prospective 
general, standardized 
/gynecologic laparoscopy  
yes=74 
no=26 
 
[1-8] (N=35)  
[9-28] (N=65) 
PONV 24h 
71.4%  
46.2% 
Beattie et al., 
1991. [10] 
Retrospective 
general, standardized 
/gynecologic laparoscopy  
yes=77 
no=158 
(N=235) 
[1-8]  
[9-end of cycle] 
PONV 24h 
51.6% 
21.6% 
Möllhoff et al., 1995. 
[11] 
Prospective  
general, two anesthesia 
techniques/ gynecologic 
laparoscopy 
yes  
[1-8] (N=41)  
[9-16] (N=57) 
[17-28] (N=52) 
PONV 24h 
29.3%  
10.5% 
15.4% 
Honkavaara et al., 
 1991 [12] 
Retrospective  
 
general, three anesthesia 
techniques/ 
gynecologic laparoscopy 
no  
[25-6] (N=11) 
[8-12] (N=22) 
[13-15] (N=22) 
[20-24] (N=13) 
PONV 24h 
18% 
32%  
54%  
77%  
Sener et al.,  
2005 [13] 
Prospective  
 
general, standardized/ 
gynecologic laparoscopy 
no  
[25- 6](N=10) 
[8-12](N=12) 
[13-15](N=10) 
[20-24](N=16) 
PONV at 2h* 
~44% 
~66% 
~27% 
~95% 
Gratz et al.,  
1996 [14] 
Retrospective  
 
Ambulatory gynecologic 
laparoscopy and/or 
non gynecologic 
yes 668 
no 205 
no PONV prophylaxis (N=205) 
[1-8] (N=63) 
[9-16] (N=70) 
[17-28] (N=50) 
[29-35](N=22) 
POV 24h 
63%  
61%  
42%  
59% 
* Estimated numbers because only figures presented 
 
Table 2. Patients’ demographics and intraoperative data.  
 
F1 
 
(n=34) 
O2 
 
(n=40) 
L3 
(n=37) 
Day of menstrual cycle 1-8 9-15 >=16 
Average length of menstrual 
cycles (days) 
27.74 (1.8) 27.85 (0.7)   28.5 (1.0)*† 
Age (yr) 31.6 (8.0) 35.6 (7.2) 34.8 (9.6) 
BMI (kg/m²) 21.9 (2. 5) 23.1 (3.4 ) 22.5 (3.6 ) 
ASA physical status (I/II) 27 / 7 37 / 3 27 / 10 
Smoking   n (%) 18 (53%) 17 (43%) 20 (54%) 
History of motion sickness 
and/or PONV    n (%) 
 
18 (53%) 
 
15 (38%) 
 
12 (32%) 
Duration of anesthesia (min) 70.26 (27.5) 65.4 (32.1)    77.8 (25.4)* 
Thiopental (mg) 322 (42.9) 326 (44.8) 322 (44.5) 
Type of surgery (n) 
    Ovarian cystectomy / 
    Tumor resection 
    Myomectomy 
    Laparoscopic assisted  
       vaginal hysterectomy 
    Procedures for infertility 
 
19 
 
9 
 
0 
6 
 
22 
 
9 
 
0 
9 
 
24 
 
8 
 
1 
4 
Risk score for PONV*  n (%) 
1 
 
9 (27%) 
 
9 (23%) 
 
12 (32%) 
2 
3 
4 
12 (35%) 
11 (32%) 
2 (6%) 
17 (43%) 
13 (33%) 
1 (3%) 
17 (46%) 
8 (22%) 
0 (0%) 
Average number of risk 
scores  
2.18 (0.9) 2.15 (0.8) 1.89 (0.7) 
 
* statistically significant  L3 vs O2, P<0.05,  
† statistically significant  L3 vs F1, P<0.05 
 
Data presented as mean (SD) or n (%).   
Simplified risk score for PONV by Apfel et al.: female gender, history of motion sickness 
or PONV, non-smoking, the use of postoperative opioids. None, one, two, three or four 
risk factors indicate 10%, 21%, 39%, 61% or 79% incidence of PONV.  
  
 
 
 
 
